Friday, February 10, 2012

Bantix supplies mosquito traps to Richard Branson's Necker Island Resort & wins Sustainable New Enterprise Award

Bantix Worldwide Limited (ASSOB: BTX) has had a series of recent positive announcements, including orders for their Mosquito Traps from Sir Richard Branson's island resorts, which are outlined in the Company's November Update.

The Company also won the "Sustainable New Enterprise 2011" at the Australian Sustainability Awards in Melbourne

To read more click here



For more information please email BlueMount Capital

Bantix announces revolutionary powerless refrigeration unit

Bantix Worldwide Limited (ASSOB: BTX), an Australian innovation and technology Company, reports that they have developed a powerless refrigeration unit for the portable consumer refrigeration market.

Managing Director Mr Andrew Coventry says the device is targeted at the global consumer market for convenient, portable and affordable refrigeration, such as “eskies” and other cooling boxes. The technology, which is the subject of a provisional patent application, has been perfected after many years of experimentation and is safe, convenient and environmentally friendly.

“The unit is unique in that it can operate at ambient temperatures in excess of 45C whilst maintaining a refrigerating temperature of between 0 and 5 degrees. It can also be used as a freezer and the unit is fully adjustable via an ingenious new control system that requires no electricity or batteries.”

“Consumers will no longer have to lug heavy, ineffective and space robbing ice in their cooling units and put up with soggy perishables and damp unhygienic conditions to store food and other sensitive items. In fact, not only is it a major step forward in technology and convenience for the market, it is more cost effective than ice” says Mr Coventry.

In other news, Mr Coventry has also announced that M-Tech International Pty Ltd, a fully owned subsidiary of Bantix, has been successful in receiving an order to supply Sir Richard Branson’s Make Peace Island with mosquito traps to protect their guests. Furthermore, two resorts in Port Macquarie have also ordered the industry leading traps after successful testing, reports the Company.

To read more click here

For more information please email BlueMount Capital

Manifesto of Light launch new ultra natural market

Manifesto of Light International Limited (ASSOB: MOL), the brainchild of businesswoman Deirdre Light and perfumer Clive Newland, will offer limited edition "ultra natural" perfumes in bejewelled vials, the first to sell for $100,000 to an exclusive invitation-only clientele, as part of its range.

The Company has appointed Melbourne based Wayne Reid OBE, a Hall of Fame Wimbledon tennis player and Director of former luxury store Georges of Melbourne, to chair the Board. The last twenty years has seen him working in Hong Kong and Europe, in the international finance area, reports the Company.

Reid is joined by ex Sydney based Graeme Johnson, whose 25 years in finance include appointments with the Macquarie Group and as Westpac Head of Group Finance.

The Company states that advisory Board Chairman, Paul Dunn, known globally as the marketing "Wizard of Wow" and chairman of the social change organization, Buy1Give1, has also joined the Company.

To read more click here

For more information please email BlueMount Capital

Manifesto of Light International

ASSOB Pty Ltd today welcomes Manifesto of Light International (ASSOB: MOL) to the Australian Small Scale Offerings Board.

BlueMount Capital is acting as the ASSOB Sponsor in connection with the Manifesto of Light International Ltd admission.


Manifesto of Light intends to bring essential oils to the global perfume and skin care market. At the core of the Company sits its high grade essential oil bank; the basis for perfume blends, skin care products and environmental blends.
 
To read more click here

For more information please email BlueMount Capital

Omega-3 could prevent & treat nerve damage

According to Qponics Limited (ASSOB: QPO) research released on the 11th January from Queen Mary University of London suggests that EPA and DHA omega-3 fatty acids found in fish and algal oil, could play a significant role in speeding recovery from nerve damage caused by accident or injury.

The study in mice focused on peripheral nerve cells, which transmit signals between the brain and the rest of the body. However, despite advances in surgical techniques, patients usually only have good recovery when their injury is minor.

Researchers simulated the type of damage caused by accident or injury, by either stretching nerve cells or starving them of oxygen, which killed a significant number of nerve cells. Increasing omega-3 fatty acid levels in cells gave them significant protection and decreased cell death. They also found that a high level of omega-3 fatty acids helped mice to recover from nerve injury more quickly and that their muscles were less likely to waste following nerve damage.

Qponics is actively developing a novel aquaponic system to grow algae for the production of algal oil high in EPA and DHA omega-3 fatty acids.

To read more click here

For more information please email BlueMount Capital



Qponics appoints new Director


Melbourne-based Dr Anthony Filippis, has joined the Board of Qponics Limited (ASSOB: QPO) as a Non-Executive Director.

Anthony is an experienced biotechnology business executive with specialist knowledge in business and corporate development. He is Co-Founder and Partner at Afandin Pty Ltd, a biotechnology-focused corporate advisory firm, specialising in assisting life science companies with their corporate strategy, business and corporate development and capital raising processes.

Anthony has held a number of senior executive roles within ASX-listed and private biotechnology companies. As Head of Corporate Development at Meditech Research Limited, he was involved in the successful completion of Australia's first merger deal between two publicly traded biotechnology companies - Meditech Research Limited and Alchemia Limited. Previously, Anthony held positions at management consulting firm KPMG and the Victorian State Government’s biotechnology commercialisation team, reports the Company.

Anthony holds a PhD in biochemistry from the University of Melbourne and an MBA from La Trobe University.

Mr Geoff Wilson, co-founder of Qponics, has retired as a Director of Qponics and will remain on the Qponics team as a communications consultant.

To read more click here

For more information please email BlueMount Capital

Opmantek release new software

Network management software Company Opmantek Limited (ASSOB: OMK) has released a candidate release of its popular NMIS version 8 software. Candidate software is Opmantek’s final stage before general release and comes after significant field-testing. 

NMIS version 8 has proven popular with the user community and Opmantek is keen to market the version 8 “add on” modules and commercial services to the 10,000 organisations that use NMIS globally. 

Opmantek Managing Director, Danny Maher says “the board is very pleased with the progress of the technology under the direction of Keith Sinclair who was recently appointed as CTO. The personalised workspace in the new User Interface and the addition of the commercial modules are seeing new customers drawn to the product, as well as existing customers motivated to upgrade.”

To read more click here

For more information please email BlueMount Capital

Wednesday, November 30, 2011

PolyGenomX Round 1 Fully Subscribed

PGX - Round 1 Fully Subscribed  - Tuesday, 22 November 2011

PolyGenomX Limited (ASSOB Code: PGX) has today filled Round 1 of its capital raising.

For more information please email BlueMount Capital

Friday, November 18, 2011

Aussie Biotech Innovator Partners with Indian Farming Giant

Queensland, Australia, November 18, 2011 –(PR.com)– A major double coup for Australian based bio-technology company PolyGenomX Ltd (PGX) was announced this week. It’s newly incorporated sister company PolyGenomX India has signed a deal within its first week of operating, with one of India’s largest enterprises the Indian Farm Forestry Development Cooperative (IFFDC), to trial its polygenomic Jatropha (Jatropha curcas pgx). This is the first stage in a collaborative R&D program to determine the best performing lines of Jatropha to provide India with on-going energy sources. Plans for future trials include polygenomic Paulownia.

Jatropha is one of the leading candidates to satisfy the rapidly growing global demand for clean, renewable aircraft biofuel, and PGX has developed the world’s fastest-growing and highest yielding variety of this plant. Interestingly, polygenomics are the product of a proprietary but natural process and therefore are not GMOs (Genetically Modified Organisms).

Identified by their unique genetic fingerprint, these “super plants” are subject to royalty. While the 2012 pilot study will cover just 50ha, the first commercial stage of the IFFDC project scheduled for 2013 is expected to extend over 1,000 ha requiring more than 1 million plants.

PolyGenomX has shown it is a company that walks its talk by partnering with such an ethical organisation, “One of our values is to work in harmony with nature and to the benefit of humanity, and IFFDC has proven through their work of developing ecologically sustainable farming practices in wasteland areas, providing employment and income for rural communities and particularly to women, that they are aligned with similar values,” says Rowe.

To read more click here

For more information please email BlueMount Capital

Thursday, November 17, 2011

Best Performing New Sponsor (www.bluemountcapital.com.au)

BlueMount Capital has won an ASSOB award for "Best Performing New Sponsor". Congratulations to the dedicated team! Read more on Page 7 of Smart Capital's latest edition.

For more information please email BlueMount Capital




 

Qponics


www.assob.com.au/qpo

Qponics is aiming to operate photo-bioreactors for the production of omega-3 oil, which will be harvested from algae rather than fish.
Latest update:
The Healthwatch column in Brisbane's Sunday Mail recently reported that the decline in global fish stocks could benefit Qponics due to the Company's focus on producing EPA/DHA omega-3 fatty acids from algae.
Qponics has reached minimum subscription and is now live on the ASSOB primary board. For more information please visit www.assob.com.au/qpo .

For more information please email BlueMount Capital




 

Opmantek



www.assob.com.au/omk
Opmantek develops, markets, packages and distributes software in the network management field. Opmantek software is used by approximately 10,000 organisations around the world.
Latest update:

Disruptive Network Management software company Opmantek has recently released a candidate release of its popular NMIS version software. Candidate software is Opmantek's final stage before general release and comes after significant field testing.

NMIS version 8 has proven popular with the user communicty and Opmantek is keen to market the version 8 "add on" modules and commercial services to the 10,000 organisations that use NMIS globally.

Opmantek is live on the ASSOB primary board. For more information please visit: www.assob.com.au/omk .

For more information please email BlueMount Capital




 

Bantix Worldwide



www.assob.com/btx
Bantix Worldwide is a technology development company. Essentially the company has come up with a way to develop, productise, market and distribute innovative products, the most substantial of which is M-Tech’s mosquito trap. Unique inventions are licensed to subsidiary companies for manufacture, marketing and sale.
Latest update:
Bantix Worldwide recently demonstrated their novel, powerlesss refrigeration unit that is set to revolutionise the portable consumer refrigeration market.
The device is targeted at the global consumer market for convenient, portable and affordable refrigeration. It can operate at ambient temperatures in excess of 45c whilst maintaining a refrigerating temperature of between 0 and 5 degrees. It can also be used as a freezer and is fully adjustable via an ingenious new control system that requires no electricity or batteries.
Bantix Worldwide is live on the ASSOB primary board. For more information please visit: www.assob.com.au/btx .

For more information please email BlueMount Capital




 


PolyGenomX



www.assob.com.au/pgx

PolyGenomX creates new polygenomic plant species “to order”, that are faster-growing, fertile, tough, versatile and high yielding compared with their peers. The core of the PolyGenomX technology is based around the activation of dormant parts of a plant's DNA without genetically modifying it in any way. The process essentially turbo charges certain naturally existing characteristics in a plant such as rapid growth properties and predispositions to thrive in various environments and soils. 
Latest Updates:
PolyGenomX has recently released a professional made video outlining its offerings to the world. Available for viewing are either the full 15 minute version, or the shorter 6 minute version.
PolyGenomX is live on the ASSOB primary board and Round 1 is almost full. For more information please visit: www.assob.com.au/pgx

For more information please email BlueMount Capital




 


Wurst-Meister - Famous German Sausages




Wurst-Meister is developing an international gourmet quick service restaurant (QSR) producing (under contract/license) freshly grilled German gourmet sausages and sausage-related products/meals including non alcoholic beverages to consumers.

Latest update:

Wurst-Meister
have now identified three possible locations in Brisbane's Queen St mall and negotiations are progressing. Speaking from the highly successful Brisbane Octoberfest, Managing Director Mick Schmidt also states that several investors are expected to sign up within the next couple of weeks. 

Please see this link for more information on Wurst-Meister:
http://www.ramscove.com.au/members-login.html

For more information please email BlueMount Capital




 

New BlueMount Web Site (www.bluemountcapital.com)


The new BlueMount Capital website is up and running, have a look here.

For more information please email BlueMount Capital




 

Thursday, September 29, 2011

Fundamental role for DHA omega-3 in maintaining mental health

A new study released last month in the United States suggests that low levels of DHA omega-3 oil in human diets leads to increased risk of major depression and suicide. Read More

For more information please email BlueMount Capital




 

PolyGenomX forms partnership in India

Jatropha is now emerging as a very valuable solution to some of the issues facing India and large-scale, professionally-managed corporations are stepping in with the goal of creating employment and income for rural communities while generating, processing and marketing commercial quantities of renewable bio-diesel.   Read More

PolyGenomX also have a brand new video available for viewing: Click Here

For more information please email BlueMount Capital




 

 

Bantix supplies mosquito traps to Richard Branson's resort

Bantix Worldwide Limited (ASSOB: BTX) reports that they have had notification that M-tech, their mosquito trap company, has won an order for supplying their mosquito traps to Richard Branson's Make Peace Island Resort.   Read More

For more information please email BlueMount Capital




 

Opmantek secures Keith Sinclair from Cisco as CTO

Opmantek Limited (ASSOB: OMK) has secured the services of Keith Sinclair in the role of Chief Technology Officer. Mr Sinclair is originally from Australia, however spent a number of years with Cisco in Silicon Valley (USA) as Technical Leader in Cisco's Advanced Service Technologies Group. Read More

For more information please email BlueMount Capital




 

Saturday, August 6, 2011

Brisbane based BlueMount Capital announce UK office


New capital investment firm BlueMount Capital has announced the opening of UK operations this week.

BlueMount Capital, formed by four highly experienced corporate advisers, delivers a broad range of funding services to sophisticated investors and private and public companies.
The firm currently has offices open in Brisbane, Sydney and Perth, and is expanding their services to operate on an international level.

Queensland managing director, Dr Mark Rainbird, says opening an office in the UK and Ireland will allow the business to take advantage of European market opportunities, in addition to facilitating local companies with overseas capital.

“Obtaining growth capital offshore rather than through limited local options can prove to be a successful move for Australian companies,” Dr Rainbird says.
“Opening an arm in the UK not only creates opportunities to obtain capital but also allows listing on major markets such as the Frankfurt Stock Exchange or the Alternative Investment Market.
“We are expanding the company and its services to capitalize on key opportunities in Europe whilst also creating worldwide networks in order to facilitate and enhance the success of capital raising for our local clients.”
Director of the UK office Benn Zemek, who is in Brisbane this week for the launch, has extensive experience in transaction origination, financial structuring, capital raising and investment management of various real estate investment strategies. 

The UK office will also service Ireland, with the assistance of director Ian Leslie, who has broad experience in the real estate industry extending from property valuation, asset and portfolio management, and acquisitions across the commercial, retail and industrial sectors.

Mr Zemek says BlueMount have been working with himself and Mr Leslie for the past 18 months on a number of real estate transactions within the UK and Ireland, which prompted the opening of the office in the region.

“The decision to open the office comes as a result of extensive work with Ian and myself, and the subsequent successful procurement of equity and debt capital for UK and Irish based real estate companies,” Mr Zemek says.

“BlueMount has been acutely focused on two key opportunities in the UK and Ireland, being the re-capitalisation of non-performing loans and investment into early stage business growth opportunities, both which benefit from the low input cost environment and strong European and US demand.
“To date we have successfully raised EUR 370m from large US and European institutions and US and Asian family offices. The funding facilities procured include equity and convertible note special private placements and senior debt.
Dr Rainbird says it is also important that companies in Australia do not restrict the potential of their capital raising by only seeking capital within the country.
“Australia is a small country with a small pool for investment which creates limitations to business owners to effectively raise capital locally,” Dr Rainbird says.
“International markets can offer a less onerous process and provide the exposure that Australian companies should be aiming for.
“Operating in the UK will generate a pathway between BlueMount Capital and international funds and stock markets, giving clients the potential to gain massive global exposure for investor capital.”

 “Bluemount Capital offers expert services and assistance from pre-IPO plans and funding, to providing Special Private Placements and floating a company on a recognized exchange.  We also deal with merger and acquisitions, private equity funding, wholesale debt and equity funding and capital raisings,” Dr Rainbird says.

“The management team are specialists in all aspects of financial transactions and have successfully completed hundreds of deals in these fields.

“Our firm’s extensive global network of professionals will also ensure a comprehensive evaluation of the most sophisticated proposals.”

For more information visit www.bluemountcapital.com.

For more information please email BlueMount Capital




 

Fast growing tree technology company

PolygenomX (ASSOB: PGX) is commercialising technology that delivers faster growth and higher yielding plants.

The Queensland-based company’s technology allows the rapid propagation of large quantities of fast growing, climate-tough, special purpose trees (and other plants) with guaranteed plant performance.
Polygenomx has the potential to double the profits of any plant plant-based enterprise, according to Rowe.
The company can create new superior variants of existing plant species by adopting and controlling a naturally occurring, but random process – the creation of polyploid plants.
In simple terms, polyploid plants absorb 50 per cent more carbon from the atmosphere year-on-year compared to non-polyploids. He says that they can then grow around 50 per cent faster for exactly the same expenditure of energy, and using the same quantities of water, nutrient and sunlight.
Roew also states that the technology has been verified by Adelaide and Queensland universities.
“Where nature works on a timeframe of eons, we are able to work on a timeframe of months,” Rowe said. “We have the ability to direct a natural process to rapidly and deliberately evolve faster-growing, tougher and more adaptable variants of any plant species.”
Polygenomx is refining its own proprietary lines of high value species - for renewable energy feedstocks in the biofuel and biomass industries; for pulp plantations; for construction timber; and for high value forestry, including Australian Teak, Kauri and Red Cedar.

To read the full article click here.

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets.

For more information please email BlueMount Capital




 

Thursday, July 21, 2011

Bio Boost Set to Clean up Mining

A $7 million bio prospect that speeds up plant growth could be the solution to remove contaminants in waste process water in the mining industry.


PolyGenomX (www.assob.com.au/pgx) is a public unlisted company that has pioneered a method to deliver faster growth and higher yields from plants to be used for biofuels, such as jatropha and other species including sandalwood for oil.


Managing director Peter Rowe says a patent is pending and commercialisation is well underway as the company seeks to identify targets in the mining industry as a solution to sustainable water management.


“Process water from mines can contain a huge amount of salt and other contaminates that if not treated properly represent a major problem for surrounding ecosystems and in turn the industry as a whole,” says Rowe.


“Treatment of process water can be expensive, particularly in remote areas and in many cases the water cannot be recycled well enough for further use. The range of PolyGenomX solutions are significantly different to what’s currently used as it’s primarily biological in nature and can even rehabilitate a mine site back to its pre-existing vegetative state.”

To read the full article click here.

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets.

For more information please email BlueMount Capital




 

Thursday, July 14, 2011

Australia’s mining mess remediated by biological boost

A ground breaking new technology could soon help one of the mining industries biggest environmental problems through plants tailored specifically to remove contaminants in waste process water. 

Australian company PolyGenomX has pioneered a method that delivers faster growth and higher yields from plants that can also be used to extract toxins from mining wastewater.

PolyGenomX managing director Peter Rowe says mining is one of the most important production activities in Australia, and the availability and proper management of water is key to its long-term sustainability.

“Process water from mines can contain a huge amount of salt and other contaminates that if not treated properly represent a major problem for surrounding ecosystems and in turn the industry as a whole,” Mr Rowe says.

“Treatment of process water can be expensive, particularly in remote areas, and in many cases the water cannot be recycled well enough for further use. 

“The range of PolyGenomX solutions are significantly different to what’s currently used as it’s primarily biological in nature and can even rehabilitate a mine site back to its pre-existing vegetative state.”

The core of the PolyGenomX technology is based around the activation of dormant parts of a plant’s DNA without genetically modifying it in any way.

The process essentially turbo charges certain naturally existing characteristics in a plant such as rapid growth properties and predispositions to thrive in various environments and soils.

“One of our many processes tailored to the mining industry is the ability to propagate trees that actively feed off salt and other contaminates, effectively stripping them out from the process water,” Mr Rowe says.
“This water can then be safely used to irrigate land and crops and even fed back into natural water courses without any recourse to the local ecosystem.

“Our technology provides water management practices that permit the mining industry to take a huge leap forward in efficient use of water resources.”

PolyGenomX has developed a number of other applications for plant use in the mining industry including controlling seepage from various areas on a site into the water table and solutions for holding ponds at the end of their life cycle.

It is currently in discussions to remediate a series of former mining sites that are presenting a number of environmental issues including the contamination of groundwater by chemicals leaching from mine tailings.
PolyGenomX is also considering the development of new bacteria-based soil-remediation technology in conjunction with the project.

Mr Rowe says the PolyGenomX technology can be adapted to a range of commercially produced crops including those used in renewable energy production and pulping through to construction and fine timber such as sandalwood.

“We have successfully developed a range of stable high-performance polygenomic species that grow faster and yield more than any comparable stock,” Mr Rowe says.

“We are able to offer a significant competitive advantage to our clients through unprecedented plant performance.

“This includes 30 percent plus faster plant growth and 30 percent plus reduction in production costs and cycles and enhanced environmental robustness.

“This all results in accelerated growth and production and significantly higher profits.”

The company will license the superior strains of plants developed to ethical producers, farmers and other partners involved in the production of commercial crops and environmental restoration.

PolyGenomX technology is a world first and has a patent pending.
BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets.

For more information please email BlueMount Capital




 

Saturday, July 9, 2011

PolyGenomX takes revolutionary Bio-Panning System to new levels

PolyGenomX Limited (ASSOB: PGX) reports that they have developed a revolutionary mine-site remediation system known as "bio-panning", with the use of specially modified Polygenomic plants in a purpose built forestry system.
This system enables the mining company to harvest any minerals or metals that may have been left in the tailings, as these are absorbed by the plants roots and then excreted through its leaves.

This system can be used for heavy metals like gold, lead, silver, copper and arsenic for reprocessing.

The Company states that one bonus of using the PolyGenomX bio-panning system lies in their tough, fast growing plants' ability to process 30% more carbon dioxide (and therefore emit 30% more oxygen) than any comparable plant species.

Click here for full article.

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets.

For more information please email BlueMount Capital




 

 

Monday, June 6, 2011

Where to go for capital? The options, the rules, the requirements for each

You’ve decided to offer equity in your company to investors in order to grow your business — but what’s the next step you need to take? In the third of this six-part series on raising capital, corporate advisor Dr Mark Rainbird discusses the avenues you have to distribute your offer to interested parties.

When you boil down the act of raising capital — regardless of how you choose to do it — it’s essentially about finding people who will support your company by giving you cash for shares. That’s it. There are several different ways that one can go about finding these individuals, however, and they all have their advantages and disadvantages.

Know Your Rules for Individuals

Investors don’t necessarily need to be obtained via an established platform like the ASX.
While you can make a personal offer to just about anyone you know, there are varying levels of disclosure that need to be made, as outlined in Section 708 of the Corporations Act.
While I’d strongly advise reading through the section yourself, the main thrust of it is that you don’t need to make disclosure if:
  • the offer is considered to be a personal one, or;
  • the investors are deemed sophisticated, or;
  • the offer is made to someone within the management of the company itself (or a member of their family), or;
  • the offer is made to a trust or company controlled by a person that meets some of the qualities that define sophisticated investors.
There are, however, further restrictions on these disclosure rules. Despite sounding like it might be a new cricket competition, the Twenty Twelve rule is one of the most significant within the capital raiser’s handbook.
Essentially, this dictates that when approaching retail investors, only 20 “concessions” are available to retail investors in a 12 month period. Additionally, Section 734 of the Corporations Act dictates that companies acquiring investors in accordance with the Twenty Twelve rule are unable to advertise or publicise their offer. It is important to note that you cannot “induce people to apply for shares.”

For more information please email BlueMount Capital


Click here for the full article

 BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets. 

Saturday, June 4, 2011

Queensland Company Leads Green Revolution

PolyGenomX (ASSOB Code: PGX), based on the Gold Coast, has pioneered a range ofprocesses that deliver faster growth and higher yields fromplants vital to a range of commercial applications and sustainable industries. 

The company’s ability to rapidly propagate fast-growing, robust and climate-tough trees and vegetation is a game-changer for the mass production of bio-fuels and feedstocks, says PolyGenomX managing director Peter Rowe. 

 "PolyGenomX has developed technology that allows us to activate dormant parts of a plant’s DNA without genetically modifying it in any way. 

 "This provides the ability to turbocharge certain characteristics naturally existing within a plant such as rapid growth properties and predispositionsto thrive in various environments and soils.


PolyGenomX will license the superior strains of plants developed to ethical producers, farmers and other partners involved in the production of commercial crops and environmental restoration.

Click here for full article. 

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets. 

For more information please email BlueMount Capital




 

 

Thursday, June 2, 2011

Raising Capital: How to Get the Money You Need


Raising Capital: How to Get the Money You Need from Alternate Sources and Empower your Capital Raising with Crowd Sourcing, Social Proof and Social Media

In May, June  and July ASSOB will be running an updated version of the very successful seminars that were run last year. The first round of seminars in Sydney, Melbourne and Brisbane have all been booked out.
"Your presentation was excellent, and greatly appreciated, especially your understanding of social proof!  It is exciting. Thank you for sharing." K.S. Newcastle
"Excellent presentation today, I found it very informative." P.B. Ballarat
The updated version features the latest techniques in the areas of Crowd Sourcing, Social Media and Social Proof.
Social Proof is the most important driver when it comes to raising capital.
This is a good opportunity to invite your prospective clients along to a professional and convincing seminar on how your clients can raise funds on the ASSOB Capital Raising Platform.

Millions of dollars are raised through the ASSOB Platform annually. Our CEO Paul Niederer will address the functionalities, methodology and the opportunities that the ASSOB Platform has within the capital raising market in Australia.

Click here for more information. 

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets. 

For more information please email BlueMount Capital




 

 

Goal of 100 companies to receive equity funding in the 2011-12 financial year

The Australian Small Scale Offerings Board (ASSOB), Australia's unique capital raising platform for equity raisings for smaller companies, has set itself the target of helping 100 companies to raise up to $100 million in the 2011-12 financial year.

Conceived more than 20 years ago as an innovative mechanism for companies to raise equity capital, ASSOB has begun to accelerate its growth of new capital raisings in the past five years, having helped more than 200 companies to obtain in excess of $130 million in new equity capital during that time.

The CEO of ASSOB, Paul Niederer, commented that the GFC had exacerbated the difficulties that small companies faced in obtaining finance from traditional sources.   "Unless you had an asset such as a house with which to anchor your loan, the banks were simply not interested in making non-asset based lending to smaller businesses.  In effect, if business owners did not have a physical asset as collateral for a loan, they have generally found banks to be pretty unsympathetic to their financing needs."

ASSOB's capital raising forums will be held in Melbourne on Thursday afternoon, May 19; in Sydney on Wednesday, May 25th;  Brisbane June 22nd,  Adelaide 5th & 6th of July and Perth 6th & 7th of July. 

Click here for full article

BlueMount Capital provides venture capital raising and Introduction services to companies seeking capital in the unlisted, pre-IPO and listed capital markets.

For more information please email BlueMount Capital




 

Tuesday, May 31, 2011

New Capital Market Firm Launched to Take Advantage of Tight Monetary Market

A new capital market firm has been launched this week to take advantage of the continuing tight monetary market and the ongoing need for funds by businesses.

BlueMount Capital, formed by four leading business identities, aims to serve sophisticated investors and private and public companies to deliver a broad range of funding services.

The firm has opened offices in Brisbane, Perth and Sydney and will be the only mid-tier firm of its kind with a national presence.

Queensland managing director, Dr Mark Rainbird, a former executive with Melbourne IT and WebCentral and managing director for Brisbane based CITEC, says traditional funders are still exercising caution and becoming even more selective in who they fund which has created a widening gap in the capital market.

“The world-wide monetary market essentially hasn’t shifted its policy on lending since the GFC, however businesses are increasingly seeking growth capital,” Dr Rainbird says.

While we’re not the only one’s to recognise this, we have managed to bring together a unique and experienced team who have access to a wide range of funding opportunities.

“Our services are especially suited to growth companies which sit at the mid to top end of the business market and require access to investment facilitation and corporate finance."

The BlueMount Capital partners include Perth based Dr Saliba Sassine who has extensive experience in resources, energy and renewables; Sydney based Len McDowall, who was previously chairman and managing partner of chartered accountants Bird Cameron; and Barry Palte who has held previous executive roles with the Commonwealth Bank and MLC.

All are experts in raising capital for business expansion, mergers and acquisitions, debt raising and equity restructuring for private and public companies.

“BlueMount Capital offers expert services and assistance from floating a company on the ASX, pre-IPO plans, IPO opportunities, MBO's, private equity funding, wholesale investing and capital raisings,” Dr Rainbird says.

“The management team are specialists in all aspects of financial transactions and have successfully completed hundreds of deals in these fields.

“Our firm’s extensive global network of professionals will also ensure a comprehensive evaluation of the most sophisticated proposals.”

For more information visit www.bluemountcapital.com.

For more information please email BlueMount Capital




 


Monday, May 30, 2011

Global Technology Remains Open With Opmantek

An Australian company has acquired the intellectual property for one of the world’s leading open source software products in the field of network management.

Queensland based Opmantek (ASSOB: OMK) has acquired and launched a new release of one of the first developed open source software programs, Network Management Information System (NMIS), which is used by approximately 10,000 organisations worldwide.

NMIS is a network management software platform that has been developed over the last 12 years and is used to manage IT networks from 1 through to 75,000 devices.

Opmantek’s open source software is free to all users, however Opmantek has developed a unique business model to capitalise on the popularity of NMIS with support packages and add-on software modules allowing the company to provide enhanced service to users at a cost.

CEO Danny Maher says open source programs are extremely popular due to their low upfront and operational costs, however lack of commercial support does cause concern for some organisations.

Click here for full article

For more information please email BlueMount Capital




 


Monday, May 23, 2011

Opmantek Ltd has today reached its Minimum Subscription

Opmantek Ltd (ASSOB: OMK) has today reached its Minimum Subscription.  For the latest news on Opmantek please see www.assob.com.au/omk  

For more information please email BlueMount Capital